Concurrent and reactivation of hepatitis B virus infection in diffuse large B-cell lymphoma: risk factors and survival outcome

Table 1 Patients characteristics according to HBsAg status

Variable	Diffuse large B-cell lymphoma		P value
Variable	HBsAg-positive	HBsAg-negative	P value
Sample size	80	166
Age, years			< 0.001
≤ 60	68 (85.0%)	105 (63.3%)
> 60	12 (15.0%)	61 (36.7%)
Gender			0.219
Male	50 (62.5%)	90 (54.2%)
Female	30 (37.5%)	76 (45.8%)
B symptom			0.002
Positive	46 (57.5%)	60 (36.1%)
Negative	34 (42.5%)	106 (63.9%)
IPI score			0.124
1–2	48 (60.0%)	116 (69.9%)
3–5	32 (40.0%)	50 (30.1%)
LDH			0.019
Normal	35 (43.8%)	99 (59.6%)
Elevated	45 (56.2%)	67 (40.4%)
Extranodal sites			0.128
< 2	44 (55.0%)	108 (65.1%)
≥ 2	36 (45.0%)	58 (34.9%)
Ann Arbor stage			0.010
I-II	19 (23.8%)	67 (40.4%)
III-IV	61 (76.3%)	99 (59.6%)

Abbreviations: HBsAg hepatitis B surface antigen, IPI international prognosis index, LDH lactate dehydrogenase

ISSN: 1750-9378